Motivation for treatment in patients with chronic cardiorenal syndrome

Efremova, E.; Shutov, A. M.; Eo, Borodulina

doi:10.17116/terarkh2015871213-17

Cited by 1 publication

(2 citation statements)

References 15 publications

(16 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Awareness of lifestyle modifications was determined using a questionnaire developed in our clinic that has been used previously in published studies [4]. Patients were asked questions clarifying the need for daily monitoring of body weight, restrictions on salt, regular physical activity.…”

Section: Adherence Assessmentmentioning

confidence: 99%

“…Chronic heart failure (CHF) is a major cause of mortality in the group of cardiovascular diseases in the world [1][2]. Low adherence to treatment is a widely extended problem among patients with CHF [3][4]. Besides medical treatment, lifestyle modifications improve the quality of life and prognosis of patients with cardiovascular diseases [5].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Adherence to Lifestyle Therapy in Patients with Chronic Heart Failure and Comorbidity

Efremova¹,

Shutov²

2019

ICFJ

View full text Add to dashboard Cite

BackgroundInfluence of comorbidity on adherence to lifestyle therapy in patients with chronic heart failure (CHF) have not been studied yet.The aimThe aim of this study was to investigate awareness and adherence to lifestyle therapy in patient with CHF and comorbidity.Мethods203 patients with CHF (130 males and 73 females, mean age was 61,8±9,6 years) were studied. CHF was defined according to ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure, 2016. Charlson comorbidity index was calculated. Awareness of lifestyle modifications was determined using a questionnaire developed in our clinic and used in previous scientific studies. Quality of life, psychological state, relation to disease were estimated. Follow-Up period was 1 year.ResultsThe awareness about lifestyle modifications in patients with CHF ranged from 38.9% (daily control of body weight) to 87.2% (reduced intake of dietary sodium). Adherence to lifestyle therapy was from 7.9% (daily weight control) to 37.9% (reduced intake of dietary sodium). Charlson comorbidity index corrected by age was 5.0±2.1 scores. Patients with high comorbidity (Charlson comorbidity index > 6 scores) had decreased of quality of life. There were not differences in adherence to lifestyle therapy in patients with CHF, depending on the level of comorbidity. Nonadherence patients were characterized by sensitive type of relation to disease, emotional lability (p< 0,05).СonclusionNonadherence to lifestyle therapy in patients with CHF is associated with desadaptive type of relation to disease, which is more common in patients with high comorbidity.

show abstract

Section: Adherence Assessmentmentioning

confidence: 99%